PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
190.98%
Net income growth 1.25-1.5x CRK's 171.84%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-0.24%
Negative yoy D&A while CRK is 198.85%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
833.18%
Well above CRK's 57.94% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
127.87%
Slight usage while CRK is negative at -109.95%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.87%
Growth of 127.87% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-991.38%
Negative yoy while CRK is 348.10%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
53.13%
Operating cash flow growth below 50% of CRK's 409.17%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-23.48%
Both yoy lines negative, with CRK at -435.19%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
451.91%
Growth well above CRK's 405.25%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-14.19%
We reduce yoy invests while CRK stands at 394.98%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-84.66%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
100.00%
Buyback growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.